Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05093673 · ClinicalTrials.gov registry record · NA

Cerebellar Stimulation for Aphasia Rehabilitation

A NA study of Stroke, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05093673: Recruiting NA study of Stroke, sponsored by Johns Hopkins University.

NCT05093673 is a NA study of Stroke that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 60 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05093673, a NA study of Stroke, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The optimal site of neuromodulation for post-stroke aphasia has yet to be established. This study will investigate whether multiple sessions of cerebellar transcranial direct current stimulation (tDCS) boosts language therapy in helping people recover from aphasia as well as predict who is likely to respond to cerebellar tDCS.

Conditions Studied

Interventions

  • DEVICE Sham
  • DEVICE Cathodal Cerebellar tDCS
  • BEHAVIORAL Semantic Feature Analysis (SFA)

Study Locations (1)

Maryland

  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-10-25
Est. Completion 2028-04-01
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT05093673

The ClinicalTrials.gov registry entry for NCT05093673 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 3 interventions - of which Sham is the first listed.

NCT05093673 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT05093673 about?

NCT05093673 is a clinical study titled "Cerebellar Stimulation for Aphasia Rehabilitation". The optimal site of neuromodulation for post-stroke aphasia has yet to be established. This study will investigate whether multiple sessions of cerebellar transcranial direct current stimulation (tDCS) boosts language therapy in helping people recover from aphasia as well as predict who is likely to...

What is the current status of trial NCT05093673?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-10-25. Estimated completion is 2028-04-01.

What conditions does trial NCT05093673 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT05093673?

The interventions under investigation include: Sham (DEVICE), Cathodal Cerebellar tDCS (DEVICE), Semantic Feature Analysis (SFA) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05093673?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05093673 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.